Survodutide – Dual Incretin/Glucagon Analog

Survodutide is an investigational peptide that acts as a dual agonist for both the
GLP-1 receptor
and the glucagon receptor.
This dual-pathway activation makes Survodutide a research compound of interest in metabolic regulation, energy expenditure, and glucose homeostasis studies.

This vial contains 10mg of high-purity Survodutide, manufactured under strict laboratory standards for advanced research use.

Research Applications

• GLP-1 & glucagon co-agonist pathway studies
• Metabolic regulation & energy balance research
• Glucose and insulin signaling models
• Appetite and satiety mechanism research
• Endocrine system and metabolic health studies

Scientific Background

Survodutide’s dual activation of GLP-1 and glucagon receptors sets it apart from traditional incretin analogs such as
Semaglutide and dual agonists like
Tirzepatide.
By engaging both pathways, Survodutide has been studied for its potential to influence energy expenditure, improve glucose regulation, and modulate metabolic function more broadly.

Chemical Profile

Type: Dual GLP-1/Glucagon receptor agonist
Targets: GLP-1 & Glucagon receptors
Form: Lyophilized powder
Purity: ≥98% (HPLC)

Manufactured in a controlled facility for in vitro laboratory research only.

Storage & Handling

Store at −20°C in a cool, dry place. After reconstitution, keep refrigerated at 2–8°C and use within the recommended stability period. Avoid repeated freeze–thaw cycles.

For Research Use Only

Survodutide 10mg is intended strictly for in vitro laboratory research and is not for human or veterinary use.

• GLP-1 – Wikipedia
• Glucagon – Wikipedia
• Glucose Metabolism – Wikipedia